PCOS Diet and Insulin Resistance: What to Eat, What to Avoid, and the Inositol Evidence

PCOS presents across four distinct phenotypes defined by the Rotterdam criteria (requiring at least two of three features: oligo/anovulation, clinical or biochemical signs of hyperandrogenism, and polycystic ovarian morphology on ultrasound). This phenotypic diversity means the condition affects women very differently.

Phenotype A (classic PCOS): hyperandrogenism + anovulation + polycystic ovaries — the most severe metabolic profile, highest prevalence of insulin resistance (approximately 75 % of affected women).

Phenotype B: hyperandrogenism + anovulation without polycystic morphology — similar metabolic risk to phenotype A.

Phenotype C: hyperandrogenism + polycystic ovaries with regular cycles — milder metabolic features, lower insulin resistance prevalence.

Phenotype D (lean PCOS or non-hyperandrogenic PCOS): anovulation + polycystic ovaries without overt androgen excess — often misdiagnosed or underdiagnosed, particularly in lean women.

This phenotypic variation matters for dietary strategy. Women with phenotypes A and B typically have the most to gain from insulin-sensitising dietary approaches. A blanket 'PCOS diet' applied without phenotype consideration can miss the mark — which is why working with a dietitian experienced in reproductive endocrinology is valuable.

In metabolic PCOS (phenotypes A and B), insulin resistance in peripheral tissues — muscle, fat, and liver — triggers compensatory hyperinsulinaemia: the pancreas produces more insulin to overcome the resistance. This chronically elevated insulin has specific and unfortunate effects on ovarian function.

Insulin receptors in the ovarian theca cells remain sensitive to insulin even when peripheral tissues are resistant. Hyperinsulinaemia stimulates these receptors, dramatically increasing androgen (primarily testosterone and androstenedione) production by the theca cells — a mechanism called selective insulin resistance.

Simultaneously, high insulin suppresses hepatic production of sex hormone-binding globulin (SHBG) — the protein that binds testosterone and reduces its bioactivity. Lower SHBG means more free, biologically active testosterone circulates even when total testosterone measurements appear normal. This explains why women with PCOS often have symptoms of androgen excess (acne, hirsutism, hair thinning) even when total testosterone falls within the reference range.

LH (luteinising hormone) is also typically elevated in PCOS, further driving theca cell androgen production and disrupting the normal LH:FSH ratio required for regular ovulation. High insulin amplifies LH pulsatility, compounding the androgenic environment.

The dietary implication is direct: reducing insulin secretion through dietary modification reduces the key driver of androgen excess in most women with PCOS.

The most consistent dietary intervention evidence in PCOS supports reducing glycaemic index and glycaemic load — not necessarily reducing carbohydrate to very low levels, but prioritising carbohydrate sources that produce lower postprandial insulin responses.

A 2021 evidence review by Szczuko et al. concluded that low-GI diets in women with PCOS produce significant improvements in fasting insulin, insulin resistance measures (HOMA-IR), total testosterone, and menstrual regularity compared with standard or high-GI dietary patterns. Even without caloric restriction, replacing high-GI carbohydrates with low-GI alternatives improves insulin sensitivity markers within 8–12 weeks.

High-GI foods to limit: white bread, white rice, instant oatmeal, breakfast cereals, sugary drinks, potatoes (particularly when boiled or mashed without fat), pastries, and most ultra-processed snacks.

Low-GI carbohydrate alternatives: legumes (lentils, chickpeas, kidney beans — among the lowest GI foods available), whole grain rye bread and pumpernickel, rolled oats (not instant), al dente pasta, basmati rice, sweet potato, most whole fruits, and non-starchy vegetables.

Caloric deficit appears to multiply these benefits: even a 5–10 % reduction in body weight in women with PCOS who are overweight produces meaningful improvements in menstrual regularity, testosterone levels, and SHBG. For lean women with PCOS, caloric deficit is not an appropriate goal; insulin sensitisation through food quality remains the primary dietary focus.

Inositol is a sugar alcohol found in many foods, particularly citrus fruits, legumes, and whole grains. It acts as a secondary messenger in insulin signalling pathways, and its deficiency — which appears to be specific to women with PCOS — impairs insulin signal transduction even when insulin itself is present at normal levels.

Two forms are relevant: myo-inositol (MI) and d-chiro-inositol (DCI). Women with PCOS appear to have impaired epimerase activity, leading to a relative deficit of d-chiro-inositol in tissues and excess myo-inositol in urine.

The clinical evidence for inositol supplementation in PCOS is among the strongest for any nutraceutical in reproductive medicine. A 2016 meta-analysis by Unfer et al. of randomised controlled trials found that myo-inositol supplementation (typically 4 g per day) significantly improved ovulation rate and menstrual regularity, fasting insulin and HOMA-IR, total and free testosterone, LH:FSH ratio, and oocyte quality in women undergoing IVF.

The combination of MI and DCI in a physiological 40:1 ratio (the ratio found in follicular fluid) appears to be more effective than either alone. Standard dosing in trials: 2 g myo-inositol + 50 mg d-chiro-inositol, twice daily. Inositol is generally well tolerated; the most common side effects at doses above 4 g daily are mild nausea and digestive discomfort.

Chronic low-grade inflammation is a feature of PCOS independent of obesity — elevated CRP, IL-6, and TNF-alpha are documented in lean women with PCOS compared with controls. This inflammatory state amplifies insulin resistance and contributes to the androgenic environment.

Foods consistently associated with worsening PCOS inflammation and insulin resistance: - Sugar-sweetened beverages: directly spike insulin and contribute to visceral fat accumulation. - Refined carbohydrates: white bread, pastries, confectionery — high GI, pro-inflammatory. - Processed and ultra-processed meat products: associated with elevated inflammatory markers. - Trans fats (partially hydrogenated oils): strongly pro-inflammatory.

Foods and patterns with evidence for benefit: - Oily fish (salmon, mackerel, sardines): omega-3 fatty acids EPA and DHA reduce inflammatory markers and may improve insulin sensitivity. - Walnuts: alpha-linolenic acid and polyphenols; a small RCT found walnut consumption improved sex hormone-binding globulin. - Cruciferous vegetables (broccoli, cauliflower, Brussels sprouts): DIM (diindolylmethane) produced in digestion supports oestrogen metabolism. - Cinnamon: multiple trials show cinnamon supplementation (1–3 g daily) improves insulin sensitivity and menstrual regularity in PCOS; the mechanism involves GLUT-4 transporter upregulation. - Spearmint tea: two cups daily of spearmint tea significantly reduced free testosterone in a small RCT — attributed to anti-androgenic activity of spearmint compounds.